| Financial Year |
March 31 2023 |
| Monetary Funds |
1,606,931,242.85 |
| Held-for-trading Financial Assets |
152,378,452.64 |
| Notes Receivable |
103,129,533.36 |
| Accounts Receivable |
360,868,102.96 |
| Advances to Suppliers |
44,372,831.66 |
| Other Receivables |
4,058,836.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
568,999,142.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,725,491.76 |
| Total Current Assets |
2,878,171,098.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
2,182,102,328.22 |
| Under-construction Projects |
704,411,236.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
224,145,555.27 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
13,630,730.65 |
| Deferred Income Tax Assets |
32,157,838.02 |
| Other Non-Current Assets |
320,634,545.38 |
| Sub-Total of Non-Current Assets |
3,501,707,265.84 |
| Total Assets |
6,379,878,364.46 |
| Short-Term Loans |
982,731,534.27 |
| Trading Financial liabilities |
-- |
| Notes Payable |
175,739,419.35 |
| Accounts Payable |
367,414,167.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
37,830,984.01 |
| Taxes Payable |
8,742,785.56 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,215,018.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
150,425,134.14 |
| Other Current Liabilities |
5,347,774.89 |
| Sub-Total of Current Liabilities |
1,737,823,339.54 |
| Long-term Loans |
158,131,700.00 |
| Bonds Payable |
811,030,129.32 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,002,682.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,078,650,290.02 |
| Total Liabilities |
2,816,473,629.56 |
| Paid-In Capital(Or Share Stock) |
481,770,753.00 |
| Capital Surplus |
1,290,081,107.89 |
| Surplus Reserve |
199,404,913.45 |
| LESS:Treasury Stock |
109,153,745.24 |
| Undistributed Profits |
1,512,485,807.96 |
| Minority Stockholder's Interest |
7,107,504.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,556,297,229.97 |
| Owner's Equity（Stockholder's Equity） |
3,563,404,734.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,379,878,364.46 |
